FIELD: medicine.
SUBSTANCE: invention relates to medicine, namely to agent for increasing resistance to hypoxia, intended for oral administration. Agent represents 0.3-0.5 % solution of hydrogen peroxide, oxygen at excess pressure of 0.2 ATM at +8 °C and drinking water.
EFFECT: invention implementation provides higher body resistance to hypoxia in conditions of respiratory distress due to additional involvement in gas exchange of gastric mucosa, intragastric ingress of oxygen in blood.
1 cl, 1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| MEANS FOR PHYSICAL ENDURANCE INCREASE | 2016 |
|
RU2634271C1 |
| ENERGY DRINK | 2016 |
|
RU2639493C1 |
| METHOD OF ENDOBRONCHIAL INJECTION OF DRUG FOR EMERGENCY ELIMINATION OF ASPHYXIA | 2024 |
|
RU2833321C1 |
| OXYGENATED WARM ALKALINE HYDROGEN PEROXIDE SOLUTION FOR INTRAPULMONARY INJECTION | 2023 |
|
RU2831821C1 |
| ALKALINE SOLUTION OF HYDROGEN PEROXIDE AND METHOD OF APPLICATION THEREOF FOR ELIMINATION OF BLOOD ASPHYXIA | 2024 |
|
RU2840645C1 |
| METHOD FOR STOMACH LAVAGE | 2014 |
|
RU2551305C1 |
| LYMPHO-SUBSITUTE FOR LOCAL MAINTAINING VIABILITY OF ORGANS AND TISSUES IN HYPOXIA AND ISCHEMIA | 2015 |
|
RU2586292C1 |
| WARM ALKALINE SOLUTION OF HYDROGEN PEROXIDE FOR INTRAPULMONARY INJECTION | 2023 |
|
RU2807851C1 |
| JELLY CANDY | 2023 |
|
RU2811131C1 |
| AEROSOL FOR INVASIVE MECHANICAL VENTILATION IN COVID-19 | 2020 |
|
RU2742505C1 |
